TITLE

If it's not integrative, it may not be translational

AUTHOR(S)
Phillipson, Eliot A.
PUB. DATE
June 2002
SOURCE
Clinical & Investigative Medicine;Jun2002, Vol. 25 Issue 3, p94
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Deals with the emergence of the translational form of clinical research. Research processes that the approach defines; Requirements in the process of translational research; Implications for academic clinical departments.
ACCESSION #
6979710

 

Related Articles

  • Clinical Trials in New Europe. DOIG, AL // Bio-IT World;Jan2009, Vol. 8 Issue 1, p13 

    The article presents an outlook for clinical trials in New Europe for 2009. The collapse of the Soviet Union is cited as one of the major factors which contributed to the emergence of new opportunity for clinical trials in Europe. An overview of the report from Insight Pharma Reports entitled...

  • Relevance of the clinical impact factor. Blitzkow, Gilson; Estrela, Carlos // Dental Press Endodontics;Jan-Apr2015, Vol. 5 Issue 1, p5 

    The author discusses the importance of systematic literature reviews to analyze clinical impact factors and select accurate and appropriate articles.

  • TRADE SECRETS.  // Applied Clinical Trials;Nov2000, Vol. 9 Issue 11, p86 

    Gives advice to clinical research professionals concerning key business concepts that apply to clinical research. Importance of recognizing the assets of clinical research organizations; Business intelligence; Standard business practices; Use of benchmarking in identifying areas for...

  • Distribution of Country of Origin in Studies Used in Cochrane Reviews. Wolff, Robert F.; Reinders, Stefan; Barth, Michael; Antes, Gerd // PLoS Clinical Trials;Apr2011, Vol. 8 Issue 4, Special section p1 

    Background and Objective: Inclusion in systematic reviews is one important component in judging the potential impact of clinical studies upon practice and hence the 'value for money' of spending for clinical research. This study aims to quantify the distribution of countries of origin of...

  • clinical trial.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p467 

    An encyclopedia entry for "clinical trial" is presented. It refers to an investigation of drug administration on human subjects to define the clinical efficacy and pharmacological effects. It addresses a variety of issues such as the treatment and diagnosis of disease. Particular focus is given...

  • Clinical trials in India: Where do we stand globally? Selvarajan, Sandhiya; George, Melvin; S., Suresh Kumar; Dkhar, Steven Aibor // Perspectives in Clinical Research;Jul-Sep2013, Vol. 4 Issue 3, p160 

    Aims: To evaluate the trend of clinical trials in India over the last 4 years compared to the well-established countries using clinical trial registries since the advent of clinical trial registry of India (CTRI). Materials and Methods: The data of clinical trials registered in India, United...

  • A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. Thabane, Lehana; Mbuagbaw, Lawrence; Zhang, Shiyuan; Samaan, Zainab; Marcucci, Maura; Chenglin Ye; Thabane, Marroon; Giangregorio, Lora; Dennis, Brittany; Kosa, Daisy; Debono, Victoria Borg; Dillenburg, Rejane; Fruci, Vincent; Bawor, Monica; Juneyoung Lee; Wells, George; Goldsmith, Charles H. // BMC Medical Research Methodology;2013, Vol. 13 Issue 1, p1 

    Background: Sensitivity analyses play a crucial role in assessing the robustness of the findings or conclusions based on primary analyses of data in clinical trials. They are a critical way to assess the impact, effect or influence of key assumptions or variations-such as different methods of...

  • Subjective endpoints in clinical trials: the case for blinded independent central review. Walovitch, Richard; Bin Yao; Chokron, Patrick; Helen Le; Bubley, Glenn // Open Access Journal of Clinical Trials;2013, Vol. 5, p111 

    Primary efficacy and safety endpoints in clinical trials are often subjective assessments made by site personnel. For international confirmatory trials conducted over broad geographic regions and different clinical practice settings, variability in these subjective assessments can be...

  • Commentary: Who pays the guideline writers? Warlow, Charles // BMJ: British Medical Journal (International Edition);3/23/2002, Vol. 324 Issue 7339, p726 

    Comments on the need for disclosure of possible conflicts of interests among clinical guideline writers. Negative impact of partnerships between industry and researchers; Argument that there needs to be more regulation.

  • Sum > parts: Building a high performance CR team.  // Clinical Trials Administrator;Dec2009, Vol. 7 Issue 12, p139 

    The article outlines steps that clinical research (CR) sites can take when developing a high performance clinical trial research team. Emphasis is given on the importance of starting a chartering process which involves understanding the team's purpose as well as the need to keep organization's...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics